The development of new chemistry-based products for pharmaceutical organizations requires the expertise of many experienced researchers. However, most early-stage companies are not equipped with the means necessary for successful scale-up and commercialization. And in an industry that is increasingly competitive, not having sufficient expertise and infrastructure can put you at a major disadvantage. Contracting a competent partner provides an opportunity to use internal resources more effectively, accelerate product development, and maintain operating budgets.
Read more about the importance of end-to-end capabilities